- Home
- KYMR vs AQN Comparison
KYMR vs AQN Comparison
Compare KYMR & AQN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- AQN
- Stock Information
- Founded
- KYMR 2015
- AQN 1988
- Country
- KYMR United States
- AQN Canada
- Employees
- KYMR N/A
- AQN N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- AQN Electric Utilities: Central
- Sector
- KYMR Health Care
- AQN Utilities
- Exchange
- KYMR Nasdaq
- AQN Nasdaq
- Market Cap
- KYMR 4.3B
- AQN 4.5B
- IPO Year
- KYMR 2020
- AQN 1998
- Fundamental
- Price
- KYMR $59.70
- AQN $5.97
- Analyst Decision
- KYMR Strong Buy
- AQN Hold
- Analyst Count
- KYMR 17
- AQN 7
- Target Price
- KYMR $63.76
- AQN $6.32
- AVG Volume (30 Days)
- KYMR 771.9K
- AQN 5.2M
- Earning Date
- KYMR 10-30-2025
- AQN 11-07-2025
- Dividend Yield
- KYMR N/A
- AQN 4.35%
- EPS Growth
- KYMR N/A
- AQN N/A
- EPS
- KYMR N/A
- AQN N/A
- Revenue
- KYMR $44,711,000.00
- AQN $2,378,238,000.00
- Revenue This Year
- KYMR $62.11
- AQN $3.43
- Revenue Next Year
- KYMR N/A
- AQN $3.79
- P/E Ratio
- KYMR N/A
- AQN N/A
- Revenue Growth
- KYMR N/A
- AQN 2.87
- 52 Week Low
- KYMR $19.45
- AQN $4.19
- 52 Week High
- KYMR $63.96
- AQN $6.24
- Technical
- Relative Strength Index (RSI)
- KYMR 62.28
- AQN 67.86
- Support Level
- KYMR $58.00
- AQN $5.78
- Resistance Level
- KYMR $63.96
- AQN $6.01
- Average True Range (ATR)
- KYMR 2.65
- AQN 0.11
- MACD
- KYMR 0.00
- AQN 0.04
- Stochastic Oscillator
- KYMR 56.84
- AQN 93.38
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About AQN Algonquin Power & Utilities Corp.
Algonquin Power & Utilities Corp is a Canada-based diversified international generation, transmission, and distribution company. The company's operations are organized across two business units consisting of the Regulated Services Group, which owns and operates a portfolio of regulated electric, water distribution and wastewater collection, and natural gas utility systems and transmission operations in the United States, Canada, Bermuda, and Chile; and the Hydro Group, which consists of hydroelectric-generating facilities located in Canada. It generates the majority of its revenue from the Regulated Services Group segment.